40% of the people on this drug "positively responded" after 5 weeks.
Better tolerated.
http://clinicaltrials.pharmaceutical-business-review.com/news/txcell-announces-positive-results-of-ovasave-in-crohns-disease-271011
Better tolerated.
http://clinicaltrials.pharmaceutical-business-review.com/news/txcell-announces-positive-results-of-ovasave-in-crohns-disease-271011
No comments:
Post a Comment
I would be delighted to hear from you.